Jeff Sharman (@jeff_sharman) 's Twitter Profile
Jeff Sharman

@jeff_sharman

Harvard/Stanford trained community practice Heme/Onc - Director of Hematology Research US Oncology - challenging white collar traditions with blue collar moxie

ID: 1532384084

linkhttps://www.linkedin.com/in/jeff-sharman-m-d-811ab71b/ calendar_today20-06-2013 00:26:36

1,1K Tweet

2,2K Followers

717 Following

Jeff Sharman (@jeff_sharman) 's Twitter Profile Photo

BTK inhibitors have transformed the lives of many patients with Chronic Lymphocytic Leukemia and other lymphomas. These drugs "exploded" onto the scene in 2013-2014 and have fundamentally changed the way we treat the disease. What many people don't know is how it all happened..